These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Functional characteristics of mucosal and connective tissue mast cells of man, the rat and other animals. Pearce FL; Ali H; Barrett KE; Befus AD; Bienenstock J; Brostoff J; Ennis M; Flint KC; Hudspith B; Johnson NM Int Arch Allergy Appl Immunol; 1985; 77(1-2):274-6. PubMed ID: 2409025 [TBL] [Abstract][Full Text] [Related]
8. [The mast cell, degranulation and pharmacological modulation of the release of mediators]. Seropian E; Filip V Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(5):385-90. PubMed ID: 6134314 [No Abstract] [Full Text] [Related]
9. Mast cells: Part II. Berman BA; Ross RN Cutis; 1984 May; 33(5):448, 450, 452 passim. PubMed ID: 6434237 [No Abstract] [Full Text] [Related]
10. Inhibition of allergic histamine release from rat peritoneal mast cells by azelastine. Interaction with selected antiasthmatic drugs. Chand N; Pillar J; Diamantis W; Sofia RD Int Arch Allergy Appl Immunol; 1988; 86(3):256-60. PubMed ID: 2456990 [TBL] [Abstract][Full Text] [Related]
11. Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease. Moriarty D; Goldhill J; Selve N; O'Donoghue DP; Baird AW Br J Pharmacol; 2001 Aug; 133(8):1346-54. PubMed ID: 11498521 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity in mast cell populations. Lee TD; Swieter M; Bienenstock J; Befus AD Clin Immunol Rev; 1985; 4(2):143-99. PubMed ID: 2417770 [No Abstract] [Full Text] [Related]
13. Mast cell mediators in asthma. Clinical uses of the inhibitors. Seropian E; Filip V; Iamandescu I Allergol Immunopathol (Madr); 1981; Suppl 9():23-7. PubMed ID: 6187197 [No Abstract] [Full Text] [Related]
14. Comparison of human lung and intestinal mast cells. Fox CC; Wolf EJ; Kagey-Sobotka A; Lichtenstein LM J Allergy Clin Immunol; 1988 Jan; 81(1):89-94. PubMed ID: 2448357 [TBL] [Abstract][Full Text] [Related]
15. Mast cell mediators with emphasis on intestinal mast cells. Metcalfe DD Ann Allergy; 1984 Dec; 53(6 Pt 2):563-75. PubMed ID: 6095703 [TBL] [Abstract][Full Text] [Related]
16. Further studies on rat mast cell degranulation by IgE-anti-IgE and the inhibitory effect of drugs related to cAMP. Kimura Y; Inoue Y; Honda H Immunology; 1974 May; 26(5):983-8. PubMed ID: 4368738 [TBL] [Abstract][Full Text] [Related]
17. A possible role for cyclic AMP in the regulation of histamine secretion and the action of cromoglycate. Foreman JC; Mongar JL; Gomperts BD; Garland LG Biochem Pharmacol; 1975 Feb; 24(4):538-40. PubMed ID: 46148 [No Abstract] [Full Text] [Related]
18. Mucosal permeability changes during intestinal reperfusion injury. The role of mast cells. Szabó A; Boros M; Kaszaki J; Nagy S Acta Chir Hung; 1997; 36(1-4):334-6. PubMed ID: 9408393 [TBL] [Abstract][Full Text] [Related]
19. The influence of endorphins on peritoneal and mucosal mast cell secretion. Shanahan F; Lee TD; Bienenstock J; Befus AD J Allergy Clin Immunol; 1984 Oct; 74(4 Pt 1):499-504. PubMed ID: 6208230 [TBL] [Abstract][Full Text] [Related]